SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001411690-24-000004
Filing Date
2024-03-05
Accepted
2024-03-05 16:23:48
Documents
18
Period of Report
2024-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bngo-20240301.htm   iXBRL 8-K 32982
2 EX-99.1 bngopressrelease-20231231.htm EX-99.1 209671
6 picture1a.jpg GRAPHIC 6865
7 picture3a.jpg GRAPHIC 3015
8 picture4a.jpg GRAPHIC 1947
  Complete submission text file 0001411690-24-000004.txt   409856

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20240301.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20240301_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20240301_pre.xml EX-101.PRE 13054
19 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20240301_htm.xml XML 2825
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 24720843
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)